Related Experiment Video
Updated: Jul 15, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Elimination of measles--South Korea, 2001-2006
Abstract:
Before the introduction of measles-containing vaccine (MCV), measles was endemic in South Korea. MCV became available in South Korea in 1965, and measles, mumps, and rubella (MMR) vaccine was added to the country's national immunization program in 1983, with 1 dose administered at age 9-15 months. In 1997, a second dose of MCV (MCV2) was added to the schedule; recommended ages for administration of MCV1 and MCV2 were 12-15 months and 4-6 years, respectively. However, with insufficient policies and programs in place to promote 2-dose coverage, this 1997 recommendation achieved limited coverage with 2 doses of MCV. In a 2000 seroepidemiologic study among children aged 7-9 years who had been eligible for vaccination since 1997, only 39% had received MCV2 (Korea Centers for Disease Control and Prevention [KCDC], unpublished data, 2001). During 2000-2001, South Korea experienced a measles epidemic that affected tens of thousands of children. In response, in 2001, South Korea announced a 5-year National Measles Elimination Plan. This report describes the activities and summarizes the results of that plan, which enabled South Korea to announce in late 2006 that interruption of indigenous measles transmission had been achieved, making South Korea the first country in the World Health Organization's (WHO) Western Pacific Region declare measles eliminated.
Insights
South Korea achieved measles elimination by implementing a 5-year National Measles Elimination Plan. This plan successfully interrupted indigenous measles transmission, marking a significant public health achievement.
Area of Science:
- Public Health
- Epidemiology
- Immunization Programs
Background:
- Measles was endemic in South Korea prior to the introduction of measles-containing vaccine (MCV).
- National immunization programs evolved, introducing a single dose of MCV in 1965 and the measles, mumps, and rubella (MMR) vaccine in 1983.
- A second MCV dose (MCV2) was added in 1997, but low coverage (39% in a 2000 study) persisted due to insufficient policy support.
Purpose of the Study:
- To describe the activities undertaken as part of South Korea's National Measles Elimination Plan.
- To summarize the results of the 5-year plan initiated in response to a 2000-2001 measles epidemic.
- To document the achievement of interrupting indigenous measles transmission in South Korea.
Main Methods:
- Implementation of a comprehensive 5-year National Measles Elimination Plan starting in 2001.
- Strengthening policies and programs to improve two-dose MCV coverage.
- Monitoring and surveillance to track measles transmission and vaccination rates.
Main Results:
- Successful interruption of indigenous measles transmission achieved by late 2006.
- South Korea became the first country in the WHO Western Pacific Region to declare measles elimination.
- The National Measles Elimination Plan effectively addressed a significant measles epidemic.
Conclusions:
- The strategic implementation of the National Measles Elimination Plan was pivotal in achieving measles elimination.
- Sustained political will and program support are crucial for successful vaccine-preventable disease eradication.
- South Korea's experience provides a model for other nations aiming for measles elimination.
Related Concept Videos
Respiratory Syncytial Virus Disease
Vaccinations
Smallpox
Poliomyelitis
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

